Better tools, faster science

GET CONNECTED
bitome.com

Team

Herbert Ryan

CEO & Co-Founder

Trevor Kemp

COO & Co-Founder

Jens Höfflin

Co-Founder & CTO

Bitome, Inc.

Company details

Bitome uses metabolomic insights to drive efficient biomanufacturing. Bitome’s magnetic-resonance/neural-network-driven platform provides quantified analysis of the cell culture environment—enabling bio-based products to get to market faster.

United StatesPre-SeedHard TechHealthcareIndustrial EquipmentHAX 09

Company News

Ginkgo Bioworks Acquires Bitome, an Integrated Metabolite Monitoring Platform

June 26, 2022
GuruFocus

Ginkgo Bioworks picks up Bitome’s AI to bolster its cell engineering platform | Fierce Biotech

June 8, 2022
Fierce Biotech

Ginkgo Bioworks Acquires Bitome, an Integrated Metabolite Monitoring Platform – WFMZ

June 7, 2022
WFMZ.com

What’s Necessary To Realize The Promise Of Digital Health Solutions?

August 30, 2019
RFWrightLSL

Heart monitor startup Bitome is first recipient of new Bayer, MassBio fellowship

July 19, 2018
Boston Business Journal

Get In Touch with Bitome, Inc.

Please tell us a little bit about yourself and why you'd like to get connected. Bitome, Inc. + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More